希玛医疗控股有限公司（03309）于2025年12月2日公告回购事宜。根据翌日披露报表显示，公司于当日回购16万股普通股，占回购前已发行股份约0.0129%。此次回购价格介乎每股1.75港元至1.76港元，合计支出约28万港元。交易完成后，公司已发行股份总数维持在1,255,560,870股，其中流通股份减少至1,237,480,870股，库藏股则增至18,080,000股。
公司回购授权于2025年5月19日获得通过，授权总数为125,556,087股，此次回购数量占决议通过当日已发行股份的约0.0129%。公告同时显示，公司确认已遵守香港联合交易所有限公司证券上市规则的相关规定。
本次公告由公司秘书陈华平签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.